Literature DB >> 6237539

Effects of 40 mcg. and 400 mcg. of ipratropium bromide in obstructive lung disease.

P Dejaegher, M Demedts, F Rochette, J Van der Veken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6237539     DOI： 10.1080/22953337.1984.11718997

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN： 1784-3286            Impact factor:   1.264


× No keyword cloud information.
  3 in total

Review 1.  Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.

Authors:  S Appleton; T Jones; P Poole; L Pilotto; R Adams; T J Lasserson; B Smith; J Muhammad
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 2.  Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease.

Authors:  S Appleton; T Jones; P Poole; L Pilotto; R Adams; T J Lasserson; B Smith; J Muhammad
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 3.  Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  D C McCrory; C D Brown
Journal:  Cochrane Database Syst Rev       Date:  2002
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.